Antihypertensives: Global Markets to 2023

Published - Feb 2019| Code - HLC159A| Analyst - BCC Research Staff

Report Highlights

The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.

Report Includes

  • 67 tables
  • Country specific data and analysis for France, Germany, Italy, U.K., Spain, Russia, India, China, Japan, United States, Canada, Middle East and Africa
  • A brief study of current and future market potential of antihypertensive drugs along with a detailed analysis of the competitive environment
  • Exposure to the industry driven underlying markets, government regulations, and technology updates
  • Coverage of regulatory dynamics, pipeline analysis, patent analysis, and market drivers, restrains, and opportunities
  • Company profiles of major manufacturers, suppliers, and supply chain participants, including Allergan Plc, Boehringer Ingelheim GMBH, Johnson & Johnson, Daiichi Sankyo Co. Ltd, Pfizer Inc. and Novartis AG

Report Scope

The current report offers a detailed analysis of the antihypertensive drug market. The study includes a discussion of antihypertensive drugs prescribed for lowering the high blood pressure and for the treatment of pulmonary arterial hypertension (PAH). The report excludes drugs used in the treatment of ocular hypertension. The market size includes both branded and generic drugs.

The report highlights the current and future market potential of antihypertensive drugs and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key market players.

The report details market shares of antihypertensive drugs based on drug class and geography. Based on drug class, the market is segmented into ACE inhibitors (angiotensin-converting enzyme inhibitors), ARBs (angiotensin II receptor blockers), beta blockers, calcium channel blockers, diuretics, combination drugs, and others (a segment that includes direct renin inhibitors, alpha blockers, PDE-5 inhibitors, stimulators of soluble guanylate cyclase, endothelin receptor antagonists, vasodilators, and prostacyclin receptors).

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Spain, Italy, Japan, China and India. For market estimates, data is provided for 2017 as the base year, with forecasts for 2018 through 2023. Estimated values are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

The BCC Research staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and who have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements, with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Antihypertensives: Global Markets to 2023 144 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Market and Technology Background7$271Free
Chapter- 4: Market Dynamics11$426Free
Chapter- 5: Market Breakdown by Drug Class27$1,046Free
Chapter- 6: Market Breakdown by Region32$1,239Free
Chapter- 7: Regulatory Environment7$271Free
Chapter- 8: Patent Analysis6$232Free
Chapter- 9: Pipeline Analysis4$155Free
Chapter- 10: Competitive Landscape5$194Free
Chapter- 11: Company Profiles36$1,394Free
Chapter- 12: Appendix: Acronyms2$77Free
 
RELATED REPORTS
Share This Report